Skip to main
NGVT

Ingevity (NGVT) Stock Forecast & Price Target

Ingevity (NGVT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Ingevity Corp demonstrates a positive outlook primarily due to its strategic execution in improving its portfolio, particularly through asset sales aimed at reducing operational complexity. This initiative is expected to enhance the company's margin profile while simultaneously decreasing earnings volatility, thereby fostering a more stable financial environment. Additionally, the company's robust revenue generation, predominantly from the Performance Chemicals segment, positions it favorably in the specialty chemicals market, reinforcing a solid foundation for future growth.

Bears say

Ingevity Corp faces significant risks that could negatively impact its earnings, particularly if there is a further decline in global auto production, which is crucial for its Performance Materials segment. The company may struggle to transition its customer base towards alternative fuel applications (AFA), potentially leading to reduced revenue and profitability. Additionally, the financial outlook is clouded by uncertainties related to patent expirations, automotive tariffs, and competitive pressures in its key markets, suggesting a challenging operating environment.

Ingevity (NGVT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ingevity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ingevity (NGVT) Forecast

Analysts have given Ingevity (NGVT) a Hold based on their latest research and market trends.

According to 2 analysts, Ingevity (NGVT) has a Hold consensus rating as of Jan 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $65, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $65, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ingevity (NGVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.